Literature DB >> 3622734

Inhibition of sensitized leukocyte's in vitro reactivity by circulating immune complexes in prostate cancer.

R Bhatti, M Shaw, P Ray.   

Abstract

Circulating immune complexes in the sera of patients with confirmed histological diagnosis of carcinoma of the prostate, were found to interfere in the sensitized leukocyte's in vitro reactivity to prostate cancer associated antigen as evaluated by tube leukocyte adherence inhibition assay, thereby suggesting an inhibitory role of such serum factors in host's anti tumor cell mediated immune responses.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3622734     DOI： 10.1007/bf01951666

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  6 in total

1.  Serum factors modifying cell mediated immunity to rat hepatoma d23 correlated with tumour growth.

Authors:  J G Bowen; R A Robins; R W Baldwin
Journal:  Int J Cancer       Date:  1975-04-15       Impact factor: 7.396

2.  Inhibition of hepatoma-immune lymph-node cell cytotoxicity by tumour-bearer serum, and solubilized hepatoma antigen.

Authors:  R W Baldwin; M R Price; R A Robins
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

3.  Enhancement of tumor outgrowth by tumor-associated blocking factors.

Authors:  K E Hellström; I Hellström
Journal:  Int J Cancer       Date:  1979-03-15       Impact factor: 7.396

4.  Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.

Authors:  H O Sjögren; I Hellström; S C Bansal; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1971-06       Impact factor: 11.205

5.  Arming of normal leukocytes with sera from patients with adenocarcinoma of the prostate.

Authors:  R A Bhatti; R J Ablin; W Condoulis; P D Guinan
Journal:  Cancer Res       Date:  1979-09       Impact factor: 12.701

6.  Responsiveness of lymphocytes to soluble extracts of prostatic tumors and abrogation by serum-blocking factor(s).

Authors:  R A Bhatti; P D Guinan; C F McKiel; I M Bush; G R Bruns; M J Flanagan; R J Ablin
Journal:  Urology       Date:  1977-03       Impact factor: 2.649
  6 in total
  1 in total

1.  Immunomodulatory effect of cyclophosphamide on host humoral immunity in Dunning's R-3327 adenocarcinoma of the prostate.

Authors:  R Bhatti; P Ray; N Bell
Journal:  Urol Res       Date:  1991
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.